The backlog in medicines registration in South Africa is a result of the implementation of pro-generics policies without strengthening the regulator to handle the substantial increase in registration applications that followed. Despite the backlog, more than enough generics are registered to promote price
No takes yet. Share an insight, caveat, or question.
Leng et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: